117 related articles for article (PubMed ID: 9052472)
1. A potential autocrine loop between heregulin-alpha and erbB-3 receptor in human prostatic adenocarcinoma.
Leung HY; Weston J; Gullick WJ; Williams G
Br J Urol; 1997 Feb; 79(2):212-6. PubMed ID: 9052472
[TBL] [Abstract][Full Text] [Related]
2. Tissue expression of neu differentiation factor/heregulin and its receptor complex in prostate cancer and its biologic effects on prostate cancer cells in vitro.
Lyne JC; Melhem MF; Finley GG; Wen D; Liu N; Deng DH; Salup R
Cancer J Sci Am; 1997; 3(1):21-30. PubMed ID: 9072304
[TBL] [Abstract][Full Text] [Related]
3. Heregulin activation of extracellular acidification in mammary carcinoma cells is associated with expression of HER2 and HER3.
Chan SD; Antoniucci DM; Fok KS; Alajoki ML; Harkins RN; Thompson SA; Wada HG
J Biol Chem; 1995 Sep; 270(38):22608-13. PubMed ID: 7673253
[TBL] [Abstract][Full Text] [Related]
4. Heregulins and the ErbB-2/3/4 receptors in gliomas.
Westphal M; Meima L; Szonyi E; Lofgren J; Meissner H; Hamel W; Nikolics K; Sliwkowski MX
J Neurooncol; 1997 Dec; 35(3):335-46. PubMed ID: 9440030
[TBL] [Abstract][Full Text] [Related]
5. ErbB-3 and ErbB-4 function as the respective low and high affinity receptors of all Neu differentiation factor/heregulin isoforms.
Tzahar E; Levkowitz G; Karunagaran D; Yi L; Peles E; Lavi S; Chang D; Liu N; Yayon A; Wen D
J Biol Chem; 1994 Oct; 269(40):25226-33. PubMed ID: 7929212
[TBL] [Abstract][Full Text] [Related]
6. ErbB kinases and NDF signaling in human prostate cancer cells.
Grasso AW; Wen D; Miller CM; Rhim JS; Pretlow TG; Kung HJ
Oncogene; 1997 Nov; 15(22):2705-16. PubMed ID: 9400997
[TBL] [Abstract][Full Text] [Related]
7. Expression of P185erbB-2, P160erbB-3, P180erbB-4, and heregulin alpha in human normal bronchial epithelial and lung cancer cell lines.
al Moustafa AE; Alaoui-Jamali M; Paterson J; O'Connor-McCourt M
Anticancer Res; 1999; 19(1A):481-6. PubMed ID: 10226586
[TBL] [Abstract][Full Text] [Related]
8. An immunological approach reveals biological differences between the two NDF/heregulin receptors, ErbB-3 and ErbB-4.
Chen X; Levkowitz G; Tzahar E; Karunagaran D; Lavi S; Ben-Baruch N; Leitner O; Ratzkin BJ; Bacus SS; Yarden Y
J Biol Chem; 1996 Mar; 271(13):7620-9. PubMed ID: 8631797
[TBL] [Abstract][Full Text] [Related]
9. The structural basis for the specificity of epidermal growth factor and heregulin binding.
Barbacci EG; Guarino BC; Stroh JG; Singleton DH; Rosnack KJ; Moyer JD; Andrews GC
J Biol Chem; 1995 Apr; 270(16):9585-9. PubMed ID: 7721889
[TBL] [Abstract][Full Text] [Related]
10. The significance of heregulin in breast cancer tumor progression and drug resistance.
Lupu R; Cardillo M; Cho C; Harris L; Hijazi M; Perez C; Rosenberg K; Yang D; Tang C
Breast Cancer Res Treat; 1996; 38(1):57-66. PubMed ID: 8825123
[TBL] [Abstract][Full Text] [Related]
11. Pathogenesis of Paget's disease: epidermal heregulin-alpha, motility factor, and the HER receptor family.
Schelfhout VR; Coene ED; Delaey B; Thys S; Page DL; De Potter CR
J Natl Cancer Inst; 2000 Apr; 92(8):622-8. PubMed ID: 10772679
[TBL] [Abstract][Full Text] [Related]
12. p53, c-erbB-2 and the epidermal growth factor receptor in the benign and malignant prostate.
Mellon K; Thompson S; Charlton RG; Marsh C; Robinson M; Lane DP; Harris AL; Horne CH; Neal DE
J Urol; 1992 Feb; 147(2):496-9. PubMed ID: 1370701
[TBL] [Abstract][Full Text] [Related]
13. Expression of p160erbB-3 and p185erbB-2 in prostatic intraepithelial neoplasia and prostatic adenocarcinoma.
Myers RB; Srivastava S; Oelschlager DK; Grizzle WE
J Natl Cancer Inst; 1994 Aug; 86(15):1140-5. PubMed ID: 7913137
[TBL] [Abstract][Full Text] [Related]
14. Expression of mRNA for heregulin and its receptor, ErbB-3 and ErbB-4, in human upper gastrointestinal mucosa.
Kataoka H; Joh T; Kasugai K; Okayama N; Moriyama A; Asai K; Kato T
Life Sci; 1998; 63(7):553-64. PubMed ID: 9718081
[TBL] [Abstract][Full Text] [Related]
15. Heregulin-dependent autocrine loop regulates growth of K-ras but not erbB-2 transformed rat thyroid epithelial cells.
Mincione G; Piccirelli A; Lazzereschi D; Salomon DS; Colletta G
J Cell Physiol; 1998 Aug; 176(2):383-91. PubMed ID: 9648926
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical detection of c-erbB-2 protein in human benign and neoplastic prostate.
Ware JL; Maygarden SJ; Koontz WW; Strom SC
Hum Pathol; 1991 Mar; 22(3):254-8. PubMed ID: 1672281
[TBL] [Abstract][Full Text] [Related]
17. NDF/heregulin stimulates the phosphorylation of Her3/erbB3.
Kita YA; Barff J; Luo Y; Wen D; Brankow D; Hu S; Liu N; Prigent SA; Gullick WJ; Nicolson M
FEBS Lett; 1994 Jul; 349(1):139-43. PubMed ID: 8045292
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of HER2 and HER4 coexpression in childhood medulloblastoma.
Gilbertson RJ; Perry RH; Kelly PJ; Pearson AD; Lunec J
Cancer Res; 1997 Aug; 57(15):3272-80. PubMed ID: 9242460
[TBL] [Abstract][Full Text] [Related]
19. Expression of androgen receptor and growth factors in premalignant lesions of the prostate.
Harper ME; Glynne-Jones E; Goddard L; Mathews P; Nicholson RI
J Pathol; 1998 Oct; 186(2):169-77. PubMed ID: 9924433
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of c-erbB-2 and epidermal growth factor receptor in stage A1 (T1a) prostatic adenocarcinoma.
Fox SB; Persad RA; Coleman N; Day CA; Silcocks PB; Collins CC
Br J Urol; 1994 Aug; 74(2):214-20. PubMed ID: 7921940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
